Phase 1/2 Studies
Identify biomarkers of response and resistance to guide your Phase 3 strategy
Identify immune biomarkers of response in peripheral blood
Profile major and minor immune cell subsets across cell states of activation, exhaustion, and senescence all in a single panel. Never miss a crucial cell subset again.

Optimize clinical dosing strategies
Immune monitoring can increase dosing accuracy by measuring immune activation at the cellular level. Optimize timing and dosing strategies via longitudinal blood-based monitoring to maximize and sustain treatment response.

Let data drive your patient selection
Enroll patients based on their unique immune fingerprint. Baseline biomarkers of response can refine patient selection for future trials and route patients to successful therapies.